<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37953468</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-6080</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Transplantation</Title><ISOAbbreviation>Transplantation</ISOAbbreviation></Journal><ArticleTitle>Long COVID Among Kidney Transplant Recipients Appears to Be Attenuated During the Omicron Predominance.</ArticleTitle><Pagination><StartPage>963</StartPage><EndPage>969</EndPage><MedlinePgn>963-969</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TP.0000000000004858</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Omicron variant has been associated with milder cases of COVID-19 among kidney transplant recipients. However, little is known about postacute sequelae, referred to as Long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Prospective, single-center cohort study investigating prevalence and risk factors for Long COVID among kidney transplant recipients during the omicron predominance in Brazil. The analysis included adult patients with confirmed SARS-CoV-2 infection between January 5, 2022, and July 18, 2022, were alive, had a functioning kidney transplant 3 mo after symptom onset, and answered a telephonic survey about physical complains of Long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From the 1529 eligible, 602 (39%) patients responded the survey. Sixteen percent reported a previous SARS-CoV-2 infection, and 85% had been fully vaccinated. The prevalence of Long COVID was 52%, with the most common complaints being weakness (46%), myalgia (41%), dizziness (33%), and headache (31%). Among employed patients, 94% were able to resume their normal work activities. In multivariable analysis, female gender (hazard ratio [HR], 2.14; 95% confidence interval [CI], 1.51-3.02; P &#x2009;&lt;&#x2009;0.0001), previous SARS-CoV-2 infection (HR, 3.55; 95% CI, 1.91-6.60; P &#x2009;&lt;&#x2009;0.0001), fatigue (HR, 2.32; 95% CI, 1.18-4.55; P &#x2009;=&#x2009;0.014), myalgia (HR, 1.48; 95% CI, 1.03-2.15; P &#x2009;=&#x2009;0.036) during the acute phase, and hospitalization because of COVID-19 (HR, 1.71; 95% CI, 1.06-2.76; P &#x2009;=&#x2009;0.028) were independently associated with Long COVID.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In the "omicron era," Long COVID among kidney transplant recipients exhibited milder characteristics and had a less significant impact on their ability to resume normal life activities. The risk factors for persistent symptoms were similar to those observed in the general population except for the vaccination status, underscoring the importance of closer monitoring in special subgroups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amorim</LastName><ForeName>Carlos Eduardo Neves</ForeName><Initials>CEN</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Physical Education, Universidade Federal do Maranh&#xe3;o, Maranh&#xe3;o, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cazetta</LastName><ForeName>Gabriela Silveira</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Transplant Division, Hospital do Rim, Funda&#xe7;&#xe3;o Oswaldo Ramos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cristelli</LastName><ForeName>Marina Pontello</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Transplant Division, Hospital do Rim, Funda&#xe7;&#xe3;o Oswaldo Ramos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Requi&#xe3;o-Moura</LastName><ForeName>Lucio Roberto</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Transplant Division, Hospital do Rim, Funda&#xe7;&#xe3;o Oswaldo Ramos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nephrology Division, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Erica Rodrigues</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Physical Education, Universidade Federal do Maranh&#xe3;o, Maranh&#xe3;o, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinheiro Vale</LastName><ForeName>Ludmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Physical Education, Universidade Federal do Maranh&#xe3;o, Maranh&#xe3;o, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brito</LastName><ForeName>Millena de Mikely Pereira</ForeName><Initials>MMP</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Physical Education, Universidade Federal do Maranh&#xe3;o, Maranh&#xe3;o, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bronzo</LastName><ForeName>Thais</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Physical Education, Universidade Federal do Maranh&#xe3;o, Maranh&#xe3;o, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Monica Rika</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Transplant Division, Hospital do Rim, Funda&#xe7;&#xe3;o Oswaldo Ramos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nephrology Division, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedesco-Silva</LastName><ForeName>Helio</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Transplant Division, Hospital do Rim, Funda&#xe7;&#xe3;o Oswaldo Ramos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nephrology Division, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina-Pestana</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Transplant Division, Hospital do Rim, Funda&#xe7;&#xe3;o Oswaldo Ramos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nephrology Division, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021/13680-6</GrantID><Agency>Funda&#xc3;&#xa7;&#xc3;&#xa3;o de Apoio &#xc3; Pesquisa do Estado de S&#xc3;&#xa3;o Paulo (FAPESP)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transplantation</MedlineTA><NlmUniqueID>0132144</NlmUniqueID><ISSNLinking>0041-1337</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066027" MajorTopicYN="N">Transplant Recipients</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37953468</ArticleId><ArticleId IdType="doi">10.1097/TP.0000000000004858</ArticleId><ArticleId IdType="pii">00007890-202404000-00022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long-COVID: an overview. Diabetes Metab Syndr. 2021;15:869&#x2013;875.</Citation></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Gemelli Against COVID-19 Post-Acute Care Study Group persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2023;401:e21&#x2013;e33.</Citation></Reference><Reference><Citation>Medina-Pestana J, Cristelli MP, Foresto RD, et al. The higher COVID-19 fatality rate among kidney transplant recipients calls for further action. Transplantation. 2022;106:908&#x2013;910.</Citation></Reference><Reference><Citation>Requi&#xe3;o-Moura LR, Sandes-Freitas TV, Viana LA, et al.; COVID-19-KT Brazil. High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: results from the Brazilian multicenter cohort study. PLoS One. 2021;16:e0254822.</Citation></Reference><Reference><Citation>Amorim CE, Gomes VL, Cristelli MP, et al. High prevalence of long-COVID among kidney transplant recipients: a longitudinal cohort study. Transplantation. 2022;106:2408&#x2013;2415.</Citation></Reference><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) dashboard. Available at https://covid19.who.int/ . Accessed April 4, 2022.</Citation></Reference><Reference><Citation>Hu FH, Jia YJ, Zhao DY, et al. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 omicron and delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients. Clin Microbiol Infect. 2023;29:835&#x2013;844.</Citation></Reference><Reference><Citation>Office for National Statistics. Self-reported long COVID after infection with the Omicron variant in the UK: 18 July 2022. Available at https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/18july2022 . Accessed June 19, 2023.</Citation></Reference><Reference><Citation>Cristelli MP, Rissoni RAP, Viana LA, et al. How did the omicron surge affect kidney transplant recipients compared with a cohort from the general population? Transplantation. 2022;106:e382&#x2013;e383.</Citation></Reference><Reference><Citation>Guimar&#xe3;es H. &#xd4;micron representa quase 100% dos genomas sequenciados pela Fiocruz [FIOCRUZ]. Available at https://portal.fiocruz.br/noticia/omicron-representa-quase-100-dos-genomas-sequenciados-pela-fiocruz . Accessed March 3, 2022.</Citation></Reference><Reference><Citation>Hern&#xe1;ndez-Aceituno A, Garc&#xed;a-Hern&#xe1;ndez A, Larumbe-Zabala E. COVID-19 long-term sequelae: omicron versus alpha and delta variants. Infect Dis Now. 2023;53:104688.</Citation></Reference><Reference><Citation>Marra AR, Sampaio VS, Ozahata MC, et al. Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020-2022. Infect Control Hosp Epidemiol. 2023;5:1&#x2013;7.</Citation></Reference><Reference><Citation>Basic-Jukic N, Juric I, Furic-Cunko V, et al. Follow-up of renal transplant recipients after acute COVID-19: a prospective cohort single-center study. Immun Inflamm Dis. 2021;9:1563&#x2013;1572.</Citation></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2022;55:101762.</Citation></Reference><Reference><Citation>Mohandas S, Jagannathan P, Henrich TJ, et al.; RECOVER Mechanistic Pathways Task Force. RECOVER Mechanistic Pathways Task Force immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023;12:e86014.</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146.</Citation></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect Dis. 2022;9:ofac464.</Citation></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>